Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 188
2
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can we prevent the transmission of BRCA mutations?

Women with the BRCA gene mutation have an 80% risk of developing breast or ovarian cancer. Most research...

Evaluating the Nutritional Status in Captive Saddle-billed Storks

Saddle-billed Storks are large, charismatic birds that are rare in captivity. The Dallas Zoo was the first...

You have mail: Stem Cell messages for fighting liver diseases

The use of stem cells is currently limited by issues including the risk of tumor formation or undesired...

Backer Badge Funded